Sun, Liyang
Hu, Zhiwen
Xie, Wa
Yang, Zhenyun
Zeng, Huilan
Zhang, Yaojun
Chen, Minshan
Hu, Dandan
Zhou, Zhongguo
Pan, Yangxun
Funding for this research was provided by:
National Natural Science Foundation of China (82103566)
Article History
Received: 22 December 2023
Accepted: 11 September 2024
First Online: 19 September 2024
Declarations
:
: The protocol complied with the ethical guidelines of the Declaration of Helsinki of the World Medical Association and was approved by the ethics committee of the Sun Yat-sen University Cancer Center (SYSUCC) (approval No. B2022-301-01). All patients provided written informed consent for HCC treatment and the use of their medical records for research purposes.
: Not applicable.
: The authors declare no competing interests.